These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17188149)

  • 1. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer.
    Sywak M; Cornford L; Roach P; Stalberg P; Sidhu S; Delbridge L
    Surgery; 2006 Dec; 140(6):1000-5; discussion 1005-7. PubMed ID: 17188149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas.
    Lin JD; Huang MJ; Hsu BR; Chao TC; Hsueh C; Liu FH; Liou MJ; Weng HF
    J Surg Oncol; 2002 May; 80(1):45-51. PubMed ID: 11967907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine level VI lymph node dissection for papillary thyroid cancer: surgical technique.
    Grodski S; Cornford L; Sywak M; Sidhu S; Delbridge L
    ANZ J Surg; 2007 Apr; 77(4):203-8. PubMed ID: 17388820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer.
    Hughes DT; White ML; Miller BS; Gauger PG; Burney RE; Doherty GM
    Surgery; 2010 Dec; 148(6):1100-6; discussion 1006-7. PubMed ID: 21134539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity?
    Alvarado R; Sywak MS; Delbridge L; Sidhu SB
    Surgery; 2009 May; 145(5):514-8. PubMed ID: 19375610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroglobulin monitoring after treatment of well-differentiated thyroid cancer.
    Hamy A; Mirallié E; Bennouna J; Resche I; Drefty C; Johnstone M; Visset J
    Eur J Surg Oncol; 2004 Aug; 30(6):681-5. PubMed ID: 15256244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer.
    Korkmaz MH; Öcal B; Saylam G; Çakal E; Bayır Ö; Tutal E; Tatar EÇ
    Langenbecks Arch Surg; 2017 Mar; 402(2):235-242. PubMed ID: 28224278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone.
    Roh JL; Park JY; Park CI
    Ann Surg; 2007 Apr; 245(4):604-10. PubMed ID: 17414610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node status influences follow-up thyroglobulin levels in papillary thyroid cancer.
    Low TH; Delbridge L; Sidhu S; Learoyd D; Robinson B; Roach P; Sywak M
    Ann Surg Oncol; 2008 Oct; 15(10):2827-32. PubMed ID: 18636294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of endoscopic thyroidectomy versus conventional open thyroidectomy in papillary thyroid microcarcinoma (PTMC) patients.
    Jeong JJ; Kang SW; Yun JS; Sung TY; Lee SC; Lee YS; Nam KH; Chang HS; Chung WY; Park CS
    J Surg Oncol; 2009 Nov; 100(6):477-80. PubMed ID: 19653245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central lymph node metastases in unilateral papillary thyroid microcarcinoma.
    Lim YC; Choi EC; Yoon YH; Kim EH; Koo BS
    Br J Surg; 2009 Mar; 96(3):253-7. PubMed ID: 19224514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.
    Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A
    Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma.
    Lang BH; Wong KP; Wan KY; Lo CY
    Ann Surg Oncol; 2012 Jan; 19(1):60-7. PubMed ID: 21681379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Algorithm for safe and effective reoperative thyroid bed surgery for recurrent/persistent papillary thyroid carcinoma.
    Farrag TY; Agrawal N; Sheth S; Bettegowda C; Ewertz M; Kim M; Tufano RP
    Head Neck; 2007 Dec; 29(12):1069-74. PubMed ID: 17563908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.
    Koo BS; Choi EC; Yoon YH; Kim DH; Kim EH; Lim YC
    Ann Surg; 2009 May; 249(5):840-4. PubMed ID: 19387316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
    Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer.
    Schuff KG; Weber SM; Givi B; Samuels MH; Andersen PE; Cohen JI
    Laryngoscope; 2008 May; 118(5):768-75. PubMed ID: 18197134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine bilateral central lymph node clearance for papillary thyroid cancer.
    Sadowski BM; Snyder SK; Lairmore TC
    Surgery; 2009 Oct; 146(4):696-703; discussion 703-5. PubMed ID: 19789029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroglobulin before ablation and correlation with posttreatment scanning.
    de Rosário PW; Guimarães VC; Maia FF; Fagundes TA; Purisch S; Padrao EL; Rezende LL; Barroso AL
    Laryngoscope; 2005 Feb; 115(2):264-7. PubMed ID: 15689747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of prophylactic lymph node dissection in the central neck area of the patients with papillary thyroid carcinoma: comparison of limited versus comprehensive lymph node dissection in a 2-year safety study.
    Son YI; Jeong HS; Baek CH; Chung MK; Ryu J; Chung JH; So YK; Jang JY; Choi J
    Ann Surg Oncol; 2008 Jul; 15(7):2020-6. PubMed ID: 18459004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.